Estimated number of deaths due to CVDs (in 000’s) by age and sex, India, 2010.

<p>Estimated number of deaths due to CVDs (in 000’s) by age and sex, India, 2010.</p

Estimated number of hospitalisation due to CVDs (in 000’s) by age and sex, India, 2004.

<p>Estimated number of hospitalisation due to CVDs (in 000’s) by age and sex, India, 2004.</p

Age and Sex Pattern of Cardiovascular Mortality, Hospitalisation and Associated Cost in India

<div><p>Context</p><p>Though the cardiovascular diseases are the leading cause of mortality in India, little is known about the human and economic loss attributed to the disease. The aim of this paper is to account the age and sex pattern of mortality, hospitalisation and the cost of hospitalisation for cardiovascular diseases in India.</p><p>Data and Methods</p><p>Data for the present study has been drawn from multiple sources; 52^nd and 60^th rounds of the National Sample Survey, Special Survey of Death, 2001–03 and the Sample Registration System 2004–2010. Under the changing demographics and constant assumptions of mortality, hospitalisation and cost of hospitalisation, we have estimated the deaths, hospitalisation and cost of hospitalisation for cardiovascular diseases in India during 2004 to 2021. Descriptive analyses and multivariate techniques were used to understand the socio-economic differentials in cost of hospitalisation for cardiovascular diseases in India.</p><p>Findings</p><p>In India, the cardiovascular diseases accounted for an estimated 1.4 million deaths in 2004 and it is likely to be 2.1 million in 2021. An estimated 6.7 million people were hospitalised for cardiovascular diseases in 2004, and projected to be 10.9 million by 2021. Unlike mortality, majority of the hospitalisation due to cardiovascular diseases will be in the prime working age group (25–59). The estimated cost of hospitalisation for cardiovascular diseases was 94/− billion rupees in 2004 and expected to be 152/− billion rupees by 2021, at 2004 prices. The cost of hospitalisation for cardiovascular diseases was significantly high in private health centres, high fertility states and among high socio-economic groups.</p><p>Conclusion</p><p>The cardiovascular mortality and hospitalisation will be largely concentrated in the prime working age group and the cost of hospitalisation is expected to increase substantially in coming years. This calls for mobilising resources, increasing access to health insurance and devising strategies for the prevention, control and treatment of cardiovascular diseases in India.</p></div

Estimated number of hospitalisation due to CVDs (in 000’s) by age and sex, India.

<p>Estimated number of hospitalisation due to CVDs (in 000’s) by age and sex, India.</p

Estimated number of hospitalisation due to CVDs (in 000’s) by age and sex, India, 2021.

<p>Estimated number of hospitalisation due to CVDs (in 000’s) by age and sex, India, 2021.</p

Estimated number of deaths due to CVDs (in 000’s) by age and sex, India, 2016.

<p>Estimated number of deaths due to CVDs (in 000’s) by age and sex, India, 2016.</p

Socio-economic differentials in hospitalisation and mean cost of hospitalisation for cardiovascular diseases, India, 1995–2004.

<p>Source: NSSO 52^nd and 60^th round.</p

Assumptions on projecting deaths, hospitalisation and cost of hospitalisation for cardiovascular diseases, India, 2004–21.

<p>Assumptions on projecting deaths, hospitalisation and cost of hospitalisation for cardiovascular diseases, India, 2004–21.</p

Estimated number of deaths due to CVDs (in 000’s) by age and sex, India, 2021.

<p>Estimated number of deaths due to CVDs (in 000’s) by age and sex, India, 2021.</p

Sensitivity analyses for the estimates of CVD deaths in India, 2010–21.

<p>Sensitivity analyses for the estimates of CVD deaths in India, 2010–21.</p